Splenectomy protects aged mice from injury after experimental stroke

• Published in: Neurobiology of aging Vol. 61; pp. 102 - 111
• Main Authors: Chauhan, Anjali, Al Mamun, Abdullah, Spiegel, Gabriel, Harris, Nia, Zhu, Liang, McCullough, Louise D.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.01.2018
• Subjects: Age; Aging - immunology; Animals; Brain - immunology; Brain Ischemia - immunology; Brain Ischemia - prevention & control; Cytokines - metabolism; Immune response; Inflammation Mediators - metabolism; Male; Mice, Inbred C57BL; Middle cerebral artery occlusion model; Spleen - immunology; Splenectomy; Stroke; Splenectomy; Middle cerebral artery occlusion model; Stroke; Immune response; Age
• ISSN: 0197-4580; 1558-1497; 1558-1497
• DOI: 10.1016/j.neurobiolaging.2017.09.022

Elderly stroke patients and aged animals subjected to experimental stroke have significantly worse functional recovery and higher mortality compared to younger subjects. Activation of the peripheral immune system is known to influence stroke outcome. Prior studies have shown that splenectomy reduces ischemic brain injury in young mice. As immune function changes with aging, it is unclear whether splenectomy will confer similar benefits in aged animals. We investigated the contribution of spleen to brain injury after cerebral ischemia in aged male mice. Splenic architecture and immune cell composition were altered in aged mice. Splenectomy 2 weeks before stroke resulted in improved neurobehavioral and infarct outcomes in aged male mice. In addition, there was a reduction in peripheral immune cell infiltration into the brain and decreased levels of peripheral inflammatory cytokines after stroke in aged splenectomized mice. Splenectomy immediately after reperfusion also improved behavioral and infarct outcomes. This study suggests that inhibition of the splenic immune response is a translationally relevant target to pursue for stroke treatment in aged individuals.